Effect of RO6871765 and RO7011785 on Immune Response With the Stimulation of Peripheral Blood Mononuclear Cells (PBMCs) in Chinese Healthy Volunteers and Chronic Hepatitis B Patients
NCT02498275 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 14
Last updated 2016-11-07
Summary
This is an exploratory study to characterize the ex vivo immune response to RO6871765 or RO7011785 stimulation of peripheral blood mononuclear cells (PBMCs) extracted from healthy volunteers and chronic hepatitis B (CHB) patients.
Conditions
- Hepatitis B, Chronic
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Clinical Trials · Hoffmann-La Roche
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-07-31
- Primary Completion
- 2014-08-31
- Completion
- 2014-08-31
Countries
- China
Study Locations
More Related Trials
-
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B
NCT03038113 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients )
NCT02964910 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB06-036 in Subjects With Chronic Hepatitis B
NCT05828745 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection
NCT03903796 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 1 Study of 162, a Novel Neutralizing Antibody Targeting Hepatitis B Surface Antigen, in Healthy Adult Subjects
NCT05310487 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability of HH-003 Injection in Participants With Chronic Hepatitis B Virus Infection
NCT05542979 ·Status: COMPLETED ·Phase: PHASE1
-
A Double-Blind Single-Ascending Dose (SAD) and Multiple-Ascending Dose (MAD) Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7049389 in Healthy Chinese Participants
NCT03570658 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Evaluate the Safety, Tolerance and Pharmacokinetic Characteristics of Single Administration of HRS-5635 Injection in Chinese Healthy Subjects and the Safety, Tolerance, Pharmacokinetics and Antiviral Effect of Multiple Administration in Patients With Chronic Hepatitis B
NCT05808374 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B
NCT04426968 ·Status: COMPLETED ·Phase: PHASE2
-
Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B
NCT07328711 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
The Treatment With HBIG+GM-CSF+HBV Vaccine for Chronic Hepatitis B Patients With HBeAg Seroconversion
NCT01878565 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of Treatment With RO6864018 in Virologically Suppressed Participants With Chronic Hepatitis B Virus (HBV) Infection
NCT02391805 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV
NCT02751996 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Safety, Tolerability, Pharmacokinetics of Single and Multiple Doses of Hepenofovir Fumarate Tablets in Healthy Volunteers.
NCT04277897 ·Status: UNKNOWN ·Phase: PHASE1
-
Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients
NCT00226447 ·Status: COMPLETED ·Phase: PHASE2
-
Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B
NCT04629976 ·Status: COMPLETED ·Phase: PHASE1
-
Study of LW231 in Participants With Chronic Hepatitis B
NCT07179575 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Single and Repeated Dose Escalation of RBD1016 in Subjects with Chronic Hepatitis B Virus (HBV) Infection
NCT05017116 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers
NCT03173599 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety, Tolerance, Pharmacokinetics Characteristics of PA3670 Tablets in Chinese Healthy Subjects
NCT05851261 ·Status: COMPLETED ·Phase: PHASE1
-
A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis B
NCT00857675 ·Status: COMPLETED ·Phase: PHASE3
-
A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B
NCT06525909 ·Status: RECRUITING
-
Phase 2 Trial of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B
NCT00869778 ·Status: COMPLETED ·Phase: PHASE2
-
A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis B
NCT03357822 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection
NCT06311734 ·Status: COMPLETED ·Phase: PHASE1